Seres Therapeutics has received US FDA breakthrough therapy designation for its ...
The US FDA has accepted a submission from GSK to review a new indication of Nuca...
Lilly’s investment and the UK government’s strategic support for life sciences a...
The prevailing treatment paradigm for newly diagnosed multiple myeloma (NDMM) pa...
InCarda Therapeutics has announced the appointment of Dr Myles Greenberg as its ...
While 88.1% of patients completed one cycle, patient adherence beyond the fourth...
The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durval...
The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics’ c...
The FDA has granted accelerated approval to Merus’ Bizengri in the treatment of ...
Dewpoint Therapeutics and MTPC have entered a strategic research partnership foc...
LEO Pharma has gained marketing authorisation from the MHRA for Anzupgo to treat...
The new FDA guidance outlines how surrogate or intermediate clinical endpoints c...
A study published in Nature estimates the economic burden associated with obesit...
Investment for companies developing cell and gene therapies (CGTs) was discussed...
Eli has announced a $3bn investment to expand its newly acquired manufacturing f...
Centenarians present a unique opportunity for researchers to explore longevity, ...
